Absence of association between genetic variation of the β3-adrenergic receptor and metabolic phenotypes in Oji-Cree

被引:22
作者
Hegele, RA
Harris, SB
Hanley, AJG
Azouz, H
Connelly, PW
Zinman, B
机构
[1] John P Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Thames Valley Family Practice Res Unit, London, ON N6A 3K7, Canada
[3] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON, Canada
[4] St Michaels Hosp, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
关键词
D O I
10.2337/diacare.21.5.851
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE -To assess the association between the common missense variant, Y64R, in the gene encoding the beta(3)-adrenergic receptor, ADRB3, and intermediate phenotypes related to obesity and NIDDM in Canadian Oji-Cree. RESEARCH DESIGN AND METHODS -We determined genotypes of the ADRB3 Y64R polymorphism in 508 clinically and biochemically well-characterized adult Oji-Cree, of whom 115 had NIDDM. We tested for associations with multivariate analysis of variance. RESULTS -We found the ADRB3 R64 allele frequency to be 0.40 in this population, which is the highest yet observed in a human population. Furthermore, 15% of subjects were R64/R64 homozygotes, compared with a virtual absence of homozygotes in European study samples. However, we found no statistically significant associations of the ADRB3 Y64R genotype either with the presence of NIDDM, with indexes of obesity, or with intermediate quantitative biochemical traits related to NIDDM. CONCLUSIONS -Despite the very high frequency of the ADRB3 R64 allele in this sample of aboriginal people, it was not associated with any metabolic phenotype. This suggests that the ADRB3 R64 allele is probably not a major determinant of obesity or NIDDM in these aboriginal Canadians.
引用
收藏
页码:851 / 854
页数:4
相关论文
共 41 条
[1]   Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant [J].
Candelore, MR ;
Deng, LP ;
Tota, LM ;
Kelly, LJ ;
Cascieri, MA ;
Strader, CD .
ENDOCRINOLOGY, 1996, 137 (06) :2638-2641
[2]   Familial aggregation of obesity, candidate genes and quantitative trait loci [J].
Chagnon, YC ;
Perusse, L ;
Bouchard, C .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) :205-211
[3]  
Clement K, 1996, INT J OBESITY, V20, P1062
[4]   GENETIC-VARIATION IN THE BETA(3)-ADRENERGIC RECEPTOR AND AN INCREASED CAPACITY TO GAIN WEIGHT IN PATIENTS WITH MORBID-OBESITY [J].
CLEMENT, K ;
VAISSE, C ;
MANNING, BS ;
BASDEVANT, A ;
GUYGRAND, B ;
RUIZ, J ;
SILVER, KD ;
SHULDINER, AR ;
FROGUEL, P ;
STROSBERG, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (06) :352-354
[5]   Role of the beta(3)-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair [J].
Elbein, SC ;
Hoffman, M ;
Barrett, K ;
Wegner, K ;
Miles, C ;
Bachman, K ;
Berkowitz, D ;
Shuldiner, AR ;
Leppert, MF ;
Hasstedt, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4422-4427
[6]   Association of Trp64Arg mutation of the beta 3-adrenergic-receptor with NIDDM and body weight gain [J].
Fujisawa, T ;
Ikegami, H ;
Yamato, E ;
Takekawa, K ;
Nakagawa, Y ;
Hamada, Y ;
Oga, T ;
Ueda, H ;
Shintani, M ;
Fukuda, M ;
Ogihara, T .
DIABETOLOGIA, 1996, 39 (03) :349-352
[7]  
Fumeron F, 1996, INT J OBESITY, V20, P1051
[8]   The Trp64Arg mutation of the beta 3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec family study and Swedish obese subjects cohorts [J].
Gagnon, J ;
Mauriege, P ;
Roy, S ;
Sjostrom, D ;
Chagnon, YC ;
Dionne, FT ;
Oppert, JM ;
Perusse, L ;
Sjostrom, L ;
Bouchard, C .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (09) :2086-2093
[9]  
HARRIS M, 1979, DIABETES, V28, P1039
[10]   The prevalence of NIDDM and associated risk factors in native Canadians [J].
Harris, SB ;
Gittelsohn, J ;
Hanley, A ;
Barnie, A ;
Wolever, TMS ;
Gao, J ;
Logan, A ;
Zinman, B .
DIABETES CARE, 1997, 20 (02) :185-187